about
Influenza and bacterial pathogen coinfections in the 20th century.Hag mediates adherence of Moraxella catarrhalis to ciliated human airway cellsEfficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children - A randomized controlled trialNon-capsulated and capsulated Haemophilus influenzae in children with acute otitis media in Venezuela: a prospective epidemiological studyNasopharyngeal microbiota in infants with acute otitis media.A novel group of Moraxella catarrhalis UspA proteins mediates cellular adhesion via CEACAMs and vitronectin.Characterization of gene use and efficacy of mouse monoclonal antibodies to Streptococcus pneumoniae serotype 8.Moraxella catarrhalis uses a twin-arginine translocation system to secrete the β-lactamase BRO-2.Influenza virus induces bacterial and nonbacterial otitis mediaAntisera Against Certain Conserved Surface-Exposed Peptides of Nontypeable Haemophilus influenzae Are Protective.Regions important for the adhesin activity of Moraxella catarrhalis HagModified lipooligosaccharide structure protects nontypeable Haemophilus influenzae from IgM-mediated complement killing in experimental otitis media.Influenza-induced inflammation drives pneumococcal otitis media.Use of the Chinchilla model to evaluate the vaccinogenic potential of the Moraxella catarrhalis filamentous hemagglutinin-like proteins MhaB1 and MhaB2.Current progress of adhesins as vaccine candidates for Moraxella catarrhalis.Antibodies mediate formation of neutrophil extracellular traps in the middle ear and facilitate secondary pneumococcal otitis media.Paediatric pneumococcal disease in Central Europe.A conserved tetranucleotide repeat is necessary for wild-type expression of the Moraxella catarrhalis UspA2 protein.Identification of gene products involved in biofilm production by Moraxella catarrhalis ETSU-9 in vitro.Moraxella catarrhalis strain O35E expresses two filamentous hemagglutinin-like proteins that mediate adherence to human epithelial cells.Resistance to complement-mediated killing and IgM binding to non-typeable Haemophilus influenzae is not altered when ascending from the nasopharynx to the middle ears in children with otitis media.Mucosal immunology down under: Special Interest Group in Mucosal Immunology workshop, Australasian Society for Immunology, Sydney, Australia, 2 December 2007.
P2860
Q30404677-E064137F-64C5-4BFF-9CED-7D1813D6ECEAQ33492145-60800BAC-8B94-4E02-9988-DA6FF9E8516DQ33848675-C722508A-DD38-4B5C-AA55-9E32F0E8E63CQ34159473-EE97BB49-9828-435B-9940-4D2662F34612Q34165102-E88BE212-22C1-4E96-B616-590878BD0FAFQ34438142-0F0E1139-CAFC-4B83-BA39-22BBAB8D755BQ34484101-062FD3D8-9D1D-462A-A3A0-BCAC69EB2801Q34778118-5823ABD6-6361-4B0D-9935-5BADF04D3641Q35532832-5D169783-BC68-4ED5-846F-233D2600EB22Q35782062-969BFD2B-05E4-4BBD-918C-2A46A28712ACQ35910752-0D9862E5-73CD-4883-8D8A-DC5DE95F4B03Q36099781-86030180-7323-418E-A0C9-BA0B33D3DF89Q36646655-38296CAF-8D54-4CCC-96C8-575AC8ADAF5BQ36976255-4BFA3F1D-6420-423B-9FE1-444B191D83F3Q37123450-F74DFD38-13C4-4261-90D7-4A5205AECB39Q37548196-009999B5-046A-4798-BA18-6C18696D2090Q37888543-FEE79C17-8A47-4F40-9D25-07C3A88689F7Q39112669-7D414884-5312-4491-A7A2-BE38B738561BQ40120991-C91D58E0-D455-48E9-A86A-F654409942DCQ42029171-5D5079EB-F4C5-4DEA-9109-4FE58808E87CQ42258577-1B14ED5E-60BC-4E6E-B769-1B34BFDAED18Q51120610-1F32C41A-6793-4050-8732-945F1D5A1E59
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Bacterial otitis media: a vaccine preventable disease?
@ast
Bacterial otitis media: a vaccine preventable disease?
@en
type
label
Bacterial otitis media: a vaccine preventable disease?
@ast
Bacterial otitis media: a vaccine preventable disease?
@en
prefLabel
Bacterial otitis media: a vaccine preventable disease?
@ast
Bacterial otitis media: a vaccine preventable disease?
@en
P2093
P1433
P1476
Bacterial otitis media: a vaccine preventable disease?
@en
P2093
Allan W Cripps
Diana C Otczyk
Jennelle M Kyd
P304
P356
10.1016/J.VACCINE.2005.01.023
P407
P577
2005-03-01T00:00:00Z